Rating History for BridgeBio Oncology Therapeutics, In (BBOT) by Stifel

More Stocks Rated by Stifel | Latest Ratings for BBOT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/6/2026 Laura Prendergast Maintain Buy
(Buy)		 23.00
(N/A)		  
 		   Details